KLG Stock +78.58% In 3 Months Since We Picked KLG Stock +78.58% In 3 Months Since We Picked Unlock All Top Buy Picks
$3.26
+0.0700 (+2.19%)
At Close: Apr 26, 2024
Forecast Earnings Dividends Fundamentals Insider Trading Signals Historical Prices Predictions News Profile

Range Low Price High Price Comment
30 days $3.05 $8.45 Friday, 26th Apr 2024 ABEO stock ended at $3.26. This is 2.19% more than the trading day before Thursday, 25th Apr 2024. During the day the stock fluctuated 5.62% from a day low at $3.20 to a day high of $3.38.
90 days $3.05 $9.01
52 weeks $2.85 $9.01

Historical Abeona Therapeutics Inc. prices

Date Open High Low Close Volume
Feb 06, 2013 $0.480 $0.490 $0.420 $0.490 25 000
Feb 05, 2013 $0.440 $0.470 $0.430 $0.470 15 000
Feb 04, 2013 $0.480 $0.480 $0.430 $0.440 25 000
Feb 01, 2013 $0.460 $0.490 $0.410 $0.480 20 000
Jan 31, 2013 $0.440 $0.490 $0.440 $0.490 5 000
Jan 30, 2013 $0.400 $0.470 $0.380 $0.470 60 000
Jan 29, 2013 $0.370 $0.420 $0.370 $0.410 30 000
Jan 28, 2013 $0.360 $0.360 $0.310 $0.360 40 000
Jan 25, 2013 $0.320 $0.360 $0.310 $0.360 5 000
Jan 24, 2013 $0.380 $0.380 $0.330 $0.380 15 000
Jan 23, 2013 $0.350 $0.380 $0.330 $0.380 20 000
Jan 22, 2013 $0.340 $0.380 $0.300 $0.380 70 000
Jan 18, 2013 $0.280 $0.340 $0.280 $0.340 40 000
Jan 17, 2013 $0.280 $0.280 $0.280 $0.280 0
Jan 16, 2013 $0.260 $0.280 $0.260 $0.280 5 000
Jan 15, 2013 $0.250 $0.280 $0.250 $0.280 15 000
Jan 14, 2013 $0.270 $0.280 $0.250 $0.280 10 000
Jan 11, 2013 $0.280 $0.280 $0.230 $0.270 80 000
Jan 10, 2013 $0.250 $0.280 $0.240 $0.280 10 000
Jan 09, 2013 $0.240 $0.250 $0.240 $0.250 10 000
Jan 08, 2013 $0.240 $0.250 $0.240 $0.250 20 000
Jan 07, 2013 $0.240 $0.250 $0.240 $0.250 45 000
Jan 04, 2013 $0.260 $0.260 $0.240 $0.250 120 000
Jan 03, 2013 $0.230 $0.260 $0.230 $0.260 210 000
Jan 02, 2013 $0.250 $0.270 $0.230 $0.270 25 000
Click to get the best stock tips daily for free!

About Abeona Therapeutics Inc.

Abeona Therapeutics. Abeona Therapeutics Inc., a clinical-stage biopharmaceutical company, develops gene and cell therapies for life-threatening rare genetic diseases. Its lead program is EB-101, an autologous, gene-corrected cell therapy that is in Phase III clinical trial for recessive dystrophic epidermolysis bullosa. The company also develops ABO-102, an adeno-associated virus (AAV)-based gene therapy for Sanfilippo syndrome type A; ABO-201 to treat CLN3 disease;... ABEO Profile

Golden Star

Ticker Date Change Price
DHT Apr 24 2.04% $11.28
MLI Apr 19 9.66% $52.28
LPLA Apr 19 1.42% $262.59
DOOR Apr 18 0.167% $131.39
LNG Apr 17 1.49% $156.81
FCN Apr 16 1.80% $207.62
ELV Apr 16 5.97% $506.97
AKR Apr 05 4.78% $16.53
ITCI Apr 05 7.04% $68.44
VSTS Apr 04 0.425% $18.82
Unlock

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT